Page last updated: 2024-08-23

balsalazide and Recrudescence

balsalazide has been researched along with Recrudescence in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kuriyama, A; Matsumura, M; Urushidani, S	1
Gibson, JA; Green, JR; Kerr, GD; Swan, CH; Swarbrick, ET; Thornton, PC	1
Aiello, F; Brandimarte, G; Elisei, W; Giorgetti, GM; Tursi, A	1

Reviews

1 review(s) available for balsalazide and Recrudescence

Article	Year
5-aminosalicylic acid agents for prevention of recurrent diverticulitis: A systematic review and meta-analysis. Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Inflammatory Agents; Databases, Bibliographic; Diverticulitis; Female; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Sulfasalazine; Treatment Outcome; Young Adult	2018

Article

Year

5-aminosalicylic acid agents for prevention of recurrent diverticulitis: A systematic review and meta-analysis.

Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Inflammatory Agents; Databases, Bibliographic; Diverticulitis; Female; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Sulfasalazine; Treatment Outcome; Young Adult

2018

Trials

2 trial(s) available for balsalazide and Recrudescence

Article	Year
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study. Alimentary pharmacology & therapeutics, 2004, Feb-15, Volume: 19, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Cohort Studies; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Patient Participation; Phenylhydrazines; Prognosis; Prospective Studies; Recurrence; Treatment Outcome	2004
Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. International journal of colorectal disease, 2007, Volume: 22, Issue:9 Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Bifidobacterium; Diverticulitis, Colonic; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Lacticaseibacillus casei; Male; Mesalamine; Middle Aged; Phenylhydrazines; Pilot Projects; Probiotics; Recurrence; Treatment Outcome	2007

Article

Year

Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study.

Alimentary pharmacology & therapeutics, 2004, Feb-15, Volume: 19, Issue:4

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Cohort Studies; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Patient Participation; Phenylhydrazines; Prognosis; Prospective Studies; Recurrence; Treatment Outcome

2004

Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon.

International journal of colorectal disease, 2007, Volume: 22, Issue:9

Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Bifidobacterium; Diverticulitis, Colonic; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Lacticaseibacillus casei; Male; Mesalamine; Middle Aged; Phenylhydrazines; Pilot Projects; Probiotics; Recurrence; Treatment Outcome

2007